Colgate-Palmolive (NYSE:CL) CFO Henning I. Jakobsen sold 858 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $74.60, for a total transaction of $64,006.80. Following the completion of the sale, the chief financial officer now owns 39,031 shares of the company’s stock, valued at $2,911,712.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
NYSE:CL traded up $0.73 during midday trading on Wednesday, reaching $72.85. 2,235,866 shares of the stock traded hands, compared to its average volume of 3,492,830. The stock has a market capitalization of $62.80 billion, a P/E ratio of 24.53, a PEG ratio of 4.71 and a beta of 0.75. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.78 and a current ratio of 1.13. The company has a fifty day moving average of $72.68 and a 200 day moving average of $70.82. Colgate-Palmolive has a 12 month low of $57.41 and a 12 month high of $76.41.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The business had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.88 billion. During the same quarter last year, the firm earned $0.77 EPS. The company’s revenue was down .5% on a year-over-year basis. On average, analysts predict that Colgate-Palmolive will post 2.84 EPS for the current fiscal year.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its position in Colgate-Palmolive by 3.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,737,377 shares of the company’s stock valued at $103,412,000 after buying an additional 57,606 shares during the period. Geode Capital Management LLC increased its stake in shares of Colgate-Palmolive by 7.9% in the 4th quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after acquiring an additional 768,550 shares in the last quarter. Stevens Capital Management LP purchased a new position in Colgate-Palmolive during the 1st quarter valued at about $11,885,000. Hurlow Wealth Management Group Inc. purchased a new position in Colgate-Palmolive during the 1st quarter valued at about $227,000. Finally, Hamilton Point Investment Advisors LLC lifted its position in Colgate-Palmolive by 1.1% during the 1st quarter. Hamilton Point Investment Advisors LLC now owns 40,015 shares of the company’s stock valued at $2,743,000 after acquiring an additional 432 shares during the period. 76.64% of the stock is currently owned by institutional investors.
Several research firms recently commented on CL. ValuEngine lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Bank of America set a $80.00 price target on shares of Colgate-Palmolive and gave the stock a “buy” rating in a research note on Friday, July 12th. Morgan Stanley upped their price target on shares of Colgate-Palmolive from $72.00 to $74.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Citigroup raised their price objective on Colgate-Palmolive from $77.00 to $79.00 and gave the company a “neutral” rating in a research note on Tuesday, August 20th. Finally, Deutsche Bank raised their price objective on Colgate-Palmolive from $74.00 to $76.00 and gave the company a “hold” rating in a research note on Friday, July 12th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and six have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $73.87.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
See Also: Leveraged Buyout (LBO)
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.